NCT02277639View on ClinicalTrials.gov

Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Bone Marrow Failure SyndromesImmunodeficienciesImmune Dysregulation Syndromes
Interventions
DEVICE

CliniMACs device

Reduced intensity conditioning with chemotherapy followed by stem cell transplant using the CliniMACs device to deplete CD3+ CD19+ peripheral stem cells.

Trial Locations (1)

19104

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

Children's Hospital of Philadelphia

OTHER

NCT02277639 - Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases | Biotech Hunter | Biotech Hunter